Access cutting-edge community acquired pneumonia in children treatment through this phase 4 clinical trial at a research site in Milwaukee. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Milwaukee location
Preparing your pre-screening questions…
Access community acquired pneumonia in children specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related community acquired pneumonia in children treatment provided free
Check if you qualify for this community acquired pneumonia in children clinical trial in Milwaukee, WI
No-Cost Study Care
Local to Milwaukee
Convenient for WI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this open label, randomized, non-inferiority clinical trial is to compare the treatment success of a 5 day antibiotic course versus a standard antibiotic course (usually 7-14 days of antibiotics) in hospitalized children aged 3 months to 18 years, with uncomplicated community acquired pneumonia. The main questions it aims to answer are: * Does a 5 day course work as well as standard (longer) courses of antibiotics for treating community acquired pneumonia in children? * Does a 5 day course cause less antibiotic side effects compared to a standard (longer) course of antibiotics in children with community acquired pneumonia? Participants will * be randomly assigned to either receive 5 total days or a total duration decided by the treating physician * receive a brief follow up questionnaire regarding clinical symptoms, follow up care/antibiotics, and side effects via phone or email at days 5 and 14 from the start of antibiotics Researchers will compare the experimental group (receiving 5 days duration) with the control group (standard duration) to see if 5 days is as successful as a standard duration.
Sponsor: Medical College of Wisconsin
Yes, this clinical trial (NCT06494072) has an active research site in Milwaukee, WI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for community acquired pneumonia in children treatment options in Milwaukee, WI, this clinical trial (NCT06494072) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Milwaukee research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced community acquired pneumonia in children specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all community acquired pneumonia in children clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in Milwaukee — not just this study.
Browse Multiple Myeloma Trials in Milwaukee →